»ó´Ü¿©¹é
±â»ç (Àüü 148°Ç)
[Late Breaking Studies] PPI, À§¾Ï °ü·Ã ¾ÈÀü¼º È®ÀÎ ÀÓ¼¼Çü ±âÀÚ 2023-01-06 18:10
[Sub Story] PPI ¾ÈÀü¼º È®ÀÎ, ¾ÆÁ÷ ³¡³ªÁö ¾Ê¾Ò´Ù? ÀÓ¼¼Çü ±âÀÚ 2023-01-06 18:00
[Interview] Àú¿ë·® PPIs·Î À§¿°Ä¡·á¿¡ »õ·Î¿î È°·Î ¸ð»ö ÀÌ»óµ· ±âÀÚ 2023-01-06 17:56
[Sub Story] ±¹³» À§¿° °ü¸®Àü·«, 8°³ Áú¹®¿¡ ´ã¾Ò´Ù ÀÓ¼¼Çü ±âÀÚ 2023-01-06 17:25
[Sub Story] PPI º´¿ë¿ä¹ýÀ¸·Î È¿°ú °­È­¡¤´ÜÁ¡ º¸¿Ï ÀÓ¼¼Çü ±âÀÚ 2023-01-06 16:56
¶óÀÎ
[Interview] ÁöÅØ, ¹Ì¶õ Ä¡·áÈ¿°ú ¶Ù¾î³­ À§¿° °ü¸® ¿É¼Ç ÀÓ¼¼Çü ±âÀÚ 2023-01-06 16:51
[Drug Review] ¹«ÄÚ½ºÅ¸, ¡®Æø³ÐÀº ±Ù°Å¡¯ÀÇ Á¡¸·º¸È£Á¦ ÀÓ¼¼Çü ±âÀÚ 2023-01-06 11:37
[Deep in Guideline] ±â´É¼º ¼ÒÈ­ºÒ·®Áõ, »ê¾ïÁ¦Á¦¿¡¼­ Ç׿ì¿ïÁ¦±îÁö Àû¿ëÇÑ´Ù ÀÓ¼¼Çü ±âÀÚ 2023-01-06 10:46
[Sub Story] NOAC ³úÁ¹Áß ¿¹¹æÇýÅà £¾ ÃâÇ÷À§Çè ÀÓ¼¼Çü ±âÀÚ 2022-12-06 10:58
[Conference Report] EASD 2022: ADA/EASD Consensus Report & UKPDS THE MOST 2022-12-05 15:14
¶óÀÎ
[Interview] ¡°ÃÊÄ¡·á¿¡ À§»ê ¿¬°ü¼º °¨º°·Î ¿µÁ¡Àâ°í
ÀÌÈÄ Áõ»ó ¼ö½Ã¡¤½Å¼ÓÁ¶Àý ¾àÁ¦·Î ¸íÁß½ÃÄѾߡ±
ÀÌ»óµ· ±âÀÚ 2022-09-05 15:15
[Late Breaking Studies] ¿¡½º¿À¸ÞÇÁ¶óÁ¹/ź»ê¼ö¼Ò³ªÆ®·ý, NERD ´ë»ó È¿°ú¡¤¾ÈÀü¼º È®º¸ ÀÓ¼¼Çü ±âÀÚ 2022-08-01 10:24
[Sub Story] GERD ºÐ·ùº° Ä¡·áÀü·« Á¤¸® ÀÓ¼¼Çü ±âÀÚ 2022-05-03 13:33
[Primary Expert Opinion] ÀÓ»óÇöÀåÀÇ ¿Ã¹Ù¸¥ Ç÷¾ÐÃøÁ¤°ú Ç÷¾Ðº¯µ¿¼º °ü¸® THE MOST 2022-05-03 13:15
[Conference Report] ¡®¼Óµµ¹®Á¦¡¯ ±Øº¹ÇÑ PPI·Î GERD Àå±â°£ Á¶ÀýÇÑ´Ù ÀÓ¼¼Çü ±âÀÚ 2022-05-03 11:35
¶óÀÎ
[Sub Story] ÀÓ»óÇöÀå¿¡¼­ °¡Á¤Ç÷¾Ð Àû±Ø Àû¿ë ÇÊ¿äÇÏ´Ù ÀÓ¼¼Çü ±âÀÚ 2022-03-08 17:50
[Sub Story] ÃÖÀûÀÇ Ä¡·á´Â Á¤È®ÇÑ Áø´ÜºÎÅÍ ÀÓ¼¼Çü ±âÀÚ 2022-01-04 14:30
[Deep in Guideline] Ŭ¶ó¸®½º·Î¸¶À̽Š³»¼º·ü °í·ÁÇÑ ºñ½º¹«½º 4Á¦¿ä¹ý ±Ç°í ÀÓ¼¼Çü ±âÀÚ 2022-01-04 14:28
[Cover Story] ¡®Ä¡·á Àü Æò°¡¡¯·Î ¸ÂÃãÄ¡·á Á¢±Ùµµ ¡è ÀÓ¼¼Çü ±âÀÚ 2022-01-04 14:28
[Sub Story] Àå±â°£ PPI Ä¡·áµµ ¾ÈÀüÇÏ´Ù ÀÓ¼¼Çü ±âÀÚ 2022-01-04 14:02
Back to Top